Akers Biosciences, Inc. FDA Inspection Record

FEI 1000121922 · Inspections, Form 483s, warning letters and import refusals

Akers Biosciences, Inc. is an FDA-inspected facility (FEI 1000121922) located in Thorofare, NJ, US. RegDataLab tracks 4 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Nov 4, 2015: No Action Indicated (NAI)
Inspections on record
4 (1 OAI, 1 VAI, 2 NAI)
Last OAI inspection
May 9, 2011
Warning letters
1 listed by FDA for this FEI, latest Oct 4, 2011

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Nov 4, 2015No Action Indicated (NAI)No citations listed
Apr 11, 2012Voluntary Action Indicated (VAI)Quality audits - Lack of or inadequate procedures (21 CFR 820.22)
Lack of or inadequate procedures - Acceptance activities (21 CFR 820.80(a))
Management review - Lack of or inadequate procedures (21 CFR 820.20(c))
Lack of or inadequate process validation (21 CFR 820.75(a))
May 9, 2011Official Action Indicated (OAI)Design changes - Lack of or Inadequate Procedures (21 CFR 820.30(i))
Documentation of software validation (21 CFR 820.70(i))
Procedures for product review,disposition lack of/inadequate (21 CFR 820.90(b)(1))
Apr 9, 2009No Action Indicated (NAI)CAPA verification/validation of corrective/preventive action (21 CFR 820.100(a)(4))
General (21 CFR 820.198(a))

FDA record score

0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 16, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

3 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIApr 11, 201210 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsOct 4, 201110 years or older, so it adds no points0
Inspection classified OAIMay 9, 201110 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Akers Biosciences, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Akers Biosciences, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Akers Biosciences, Inc.
Location
Thorofare, NJ (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.